KPIs & Operating Metrics(New)
Growth Metrics

Medtronic (MDT) Depreciation & Amortization (CF) (2016 - 2026)

Medtronic's Depreciation & Amortization (CF) history spans 13 years, with the latest figure at $749.0 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 9.5% to $749.0 million in Q1 2026 year-over-year; TTM through Jan 2026 was $3.1 billion, a 15.21% increase, with the full-year FY2025 number at $2.9 billion, up 8.08% from a year prior.
  • Depreciation & Amortization (CF) hit $749.0 million in Q1 2026 for Medtronic, up from $745.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for MDT hit a ceiling of $840.0 million in Q2 2025 and a floor of $649.0 million in Q1 2024.
  • Historically, Depreciation & Amortization (CF) has averaged $694.5 million across 5 years, with a median of $675.0 million in 2024.
  • Biggest five-year swings in Depreciation & Amortization (CF): dropped 4.42% in 2024 and later rose 28.44% in 2025.
  • Tracing MDT's Depreciation & Amortization (CF) over 5 years: stood at $671.0 million in 2022, then rose by 0.15% to $672.0 million in 2023, then rose by 0.45% to $675.0 million in 2024, then rose by 10.37% to $745.0 million in 2025, then rose by 0.54% to $749.0 million in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for MDT at $749.0 million in Q1 2026, $745.0 million in Q4 2025, and $748.0 million in Q3 2025.